Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM

Sarvenaz Sarabipour1, Kalina Hristova1

  • 1Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21212, USA.

Insights

Pathogenic cysteine mutations in fibroblast growth factor receptors (FGFRs) stabilize receptor dimers, altering their structure. This aberrant dimerization and structural changes likely drive disease phenotypes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Missense mutations altering cysteine residues in receptor tyrosine kinases (RTKs) are linked to pathologies.
  • These mutations are hypothesized to cause disease by stabilizing active RTK dimers.
  • The stabilizing effect of such mutations on full-length receptors remains unquantified.

Purpose of the Study:

  • To measure the dimer stabilizing effects of pathogenic cysteine substitutions in full-length fibroblast growth factor receptors (FGFRs).
  • To investigate the impact of these mutations on the structural configuration of FGFR transmembrane dimers.

Main Methods:

  • Characterization of dimer stabilities for three full-length FGFR mutants (C178S FGFR1, C342R FGFR2, C228R FGFR3).
  • Analysis of the structural configuration of transmembrane FGFR dimers.

Main Results:

  • The three studied cysteine substitution mutations significantly stabilize FGFR dimers.
  • These mutations were observed to alter the structural configuration of the FGFR transmembrane dimers.

Conclusions:

  • Aberrant dimerization is a likely contributor to pathological phenotypes caused by these FGFR mutations.
  • Perturbed dimer structure resulting from these mutations also likely contributes to disease.
  • Quantifying dimer stability provides insight into the molecular mechanisms of RTK-related pathologies.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1000
Mutations01:39

Mutations

Overview
95.7K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K